7-Feb-2025
Co-located cell types help drive aggressive brain tumors
Johns Hopkins MedicinePeer-Reviewed Publication
A type of aggressive, treatment-resistant brain tumor has a distinct population of immune cells that support its growth, according to new research led by investigators at the Johns Hopkins Kimmel Cancer Center Bloomberg~Kimmel Institute for Cancer Immunotherapy and the Johns Hopkins University School of Medicine.
- Journal
- Science
- Funder
- NIH/National Institutes of Health, NIH/National Institutes of Health, NIH/National Institutes of Health, NIH/National Institutes of Health, NIH/National Institutes of Health, Neurosurgery Research Education Foundation, Bloomberg~Kimmel Institute for Cancer Immunotherapy, Mark Foundation For Cancer Research, Burroughs Wellcome Career Award for Medical Scientists, Commonwealth Foundation, Maryland Cigarette Restitution Fund and the NIH Pioneer Award